MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

105 hedge funds and large institutions have $592M invested in Marinus Pharmaceuticals, Inc in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 19 closing their positions.

Holders
105
Holders Change
+1
Holders Change %
+0.96%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
21
Increased
35
Reduced
33
Closed
19
Calls
$12.9M
Puts
$826K
Net Calls
+$12.1M
Net Calls Change
+$1.27M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$12.7M
2
SI
2
Sofinnova Investments
California
$19.3M
3
CAM
3
Cormorant Asset Management
Massachusetts
$35.3M
4
Aberdeen Group
4
Aberdeen Group
United Kingdom
$6.01M
5
SCM
5
Superstring Capital Management
New York
$5.03M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$5.36M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$28.1M
3
BFM
3
Boothbay Fund Management
New York
$1.76M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$2.95M
5
SSA
5
Schonfeld Strategic Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SCM
1
Suvretta Capital Management
New York
$58.1M 5,346,119 +141,177 +3%
BlackRock
2
BlackRock
New York
$50M 4,599,278 +453,635 +11%
EAM
3
Eventide Asset Management
Massachusetts
$49.2M 4,529,997 – –
Franklin Resources
4
Franklin Resources
California
$41.7M 3,833,955 +49,589 +1%
CAM
5
Cormorant Asset Management
Massachusetts
$35.3M 3,250,000 +625,000 +24%
ACA
6
Avoro Capital Advisors
New York
$34.2M 3,150,000 – –
Jennison Associates
7
Jennison Associates
New York
$32.2M 2,959,161 +3,818 +0.1%
Vanguard Group
8
Vanguard Group
Pennsylvania
$29.1M 2,673,231 +95,756 +4%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$28.1M 2,581,250 -323,226 -11%
LPC
10
Lion Point Capital
New York
$23.2M 2,134,337 -11,000 -0.5%
BL
11
Bleichroeder LP
New York
$20.4M 1,872,463 – –
SI
12
Sofinnova Investments
California
$19.3M 1,772,699 +787,093 +80%
GC
13
GMT Capital
Georgia
$18.7M 1,722,695 – –
BCLSI
14
Bain Capital Life Sciences Investors
Massachusetts
$15.6M 1,431,058 – –
Morgan Stanley
15
Morgan Stanley
New York
$12.7M 1,167,590 +1,120,443 +2,376%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$12.4M 1,139,494 +94,546 +9%
State Street
17
State Street
Massachusetts
$10.9M 1,005,907 +10,352 +1%
WP
18
Woodline Partners
California
$8.7M 800,000 +168,480 +27%
IC
19
Ikarian Capital
Texas
$8.11M 746,069 – –
Citadel Advisors
20
Citadel Advisors
Florida
$6.48M 596,396 +118,387 +25%
OM
21
Opaleye Management
Massachusetts
$6.13M 563,500 -20,500 -4%
Aberdeen Group
22
Aberdeen Group
United Kingdom
$6.01M 552,572 +552,572 New
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$5.36M 493,400 -571,637 -54%
SCM
24
Superstring Capital Management
New York
$5.03M 462,444 +462,444 New
Northern Trust
25
Northern Trust
Illinois
$4.99M 459,085 +28,858 +7%
1
2 3 4 5